Table 2. Tuberculosis Case Management Indicators by Clinic Site of Care, Alberta, 2008–2012.
| Clinic Site of Care* | |||||
|---|---|---|---|---|---|
| Indicator | Target | All Clinics | Virtual Clinic | Outpatient Clinics | p-value |
| (%) | n (%) | n (%) | n (%) | ||
| TB Cases | 841 | 150 | 691 | ||
| HIV tested † | >90 | 798 (95) | 145 (99) | 653 (95) | 0.33 |
| [3] | [1] | ||||
| Pediatric cases <5 years of age | <5 | 21 (3) | 5 (3) | 16 (2) | 0.56 |
| Culture-positive TB cases | 75–85 | 709 (84) | 131 (87) | 578 (84) | 0.26 |
| DST results reported | 100 | 701 (99) | 131 (100) | 570 (99) | 0.36 |
| Genotype reported | 100 | 694 (98) | 130 (99) | 564 (98) | 0.33 |
| Smear-positive PTB cases ‡ | 237 | 50 | 187 | ||
| Followed to 3 smears negative | 100 | 142 (63) | 43 (93) | 99 (55) | 0.001 |
| [4] | [7] | ||||
| End of initial phase culture | 90 | 163 (72) | 23 (50) | 140 (78) | 0.01 |
| [4] | [8] | ||||
| End of initial phase CXR | 100 | 147 (65) | 24 (52) | 123 (68) | <0.05 |
| [4] | [6] | ||||
| End of continuation phase culture | 50 | 98 (46) | 25 (58) | 73 (43) | 0.07 |
| [7] | [17] | ||||
| End of continuation phase CXR | 100 | 175 (83) | 32 (76) | 143 (84) | 0.23 |
| [8] | [17] | ||||
Abbreviations: DST drug susceptibility test; PTB pulmonary tuberculosis; HIV human immunodeficiency virus; CXR chest x-ray
* See text for definition of clinic type and phase of treatment
† Patients who were diagnosed at death may not have been HIV tested. If not they are listed in square brackets beneath the indicator result and excluded from the denominator.
‡ Patients who died or were transferred out in the interim are listed in square brackets beneath the indicator result and excluded from the denominator